Saturday, July 11, 2026

Drug profile · INN

samrotecan

samrotecan is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — samrotecan
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

samrotecan is an FDA-listed pharmaceutical active ingredient.

Key facts

INN samrotecan

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Puxitatug Samrotecan Phase 3 · AstraZeneca · Endometrial Cancer

Frequently asked questions

What is samrotecan?

samrotecan is an FDA-listed pharmaceutical active ingredient.